Cognition Therapeutics Inc (CGTX) concluded trading on Wednesday at a closing price of $0.58, with 288.38 million shares of worth about $167.26 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -71.57% during that period and on December 18, 2024 the price saw a gain of about 27.50%. Currently the company’s common shares owned by public are about 40.81M shares, out of which, 35.21M shares are available for trading.
Stock saw a price change of 19.29% in past 5 days and over the past one month there was a price change of 25.35%. Year-to-date (YTD), CGTX shares are showing a performance of -68.65% which decreased to -65.88% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.34 but also hit the highest price of $2.95 during that period. The average intraday trading volume for Cognition Therapeutics Inc shares is 1.54 million. The stock is currently trading 32.76% above its 20-day simple moving average (SMA20), while that difference is up 23.47% for SMA50 and it goes to -53.50% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cognition Therapeutics Inc (NASDAQ: CGTX) currently have 40.81M outstanding shares and institutions hold larger chunk of about 10.36% of that.
The stock has a current market capitalization of $24.10M and its 3Y-monthly beta is at 1.24. It has posted earnings per share of -$0.96 in the same period. It has Quick Ratio of 2.11 while making debt-to-equity ratio of 0.04. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CGTX, volatility over the week remained 34.79% while standing at 16.03% over the month.
Stock’s fiscal year EPS is expected to drop by -0.78% while it is estimated to increase by 13.00% in next year.
Coverage by Oppenheimer stated Cognition Therapeutics Inc (CGTX) stock as an Outperform in their note to investors on November 03, 2021, suggesting a price target of $22 for the stock.
